Cargando…

Galectin-3 Inhibition Ameliorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice

OBJECTIVE: Diabetic cardiomyopathy (DCM), characterized by cardiomyopathy with the absence of coronary artery disease, hypertension, and valvular heart disease in patients with diabetes, significantly increases the risk of heart failure. Galectin-3 (Gal-3) has been shown to regulate cardiac inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Ning, Zhu, Liuyan, Huang, Bingwu, Xiang, Wenjun, Zhao, Xuyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086782/ https://www.ncbi.nlm.nih.gov/pubmed/35557520 http://dx.doi.org/10.3389/fcvm.2022.868372

Ejemplares similares

Bibliometric analysis of the inflammation in diabetic cardiomyopathy
por: Zhu, Ning, et al.
Publicado: (2022)

Celastrol attenuates streptozotocin-induced diabetic cardiomyopathy in mice by inhibiting the ACE / Ang II / AGTR1 signaling pathway
por: Zhao, Xuyong, et al.
Publicado: (2023)

Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking
por: Zhu, Ning, et al.
Publicado: (2021)

Triptolide attenuates irritable bowel syndrome via inhibiting ODC1
por: Zhu, Ning, et al.
Publicado: (2023)

Activated Protein C Ameliorates Diabetic Cardiomyopathy via Modulating OTUB1/YB-1/MEF2B Axis
por: Zhong, Xiaodan, et al.
Publicado: (2021)

Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse
por: Salim, Hotimah Masdan, et al.
Publicado: (2016)

S-Propargyl-Cysteine Attenuates Diabetic Cardiomyopathy in db/db Mice Through Activation of Cardiac Insulin Receptor Signaling
por: Li, Ye, et al.
Publicado: (2021)

Functional components of Chinese rice wine can ameliorate diabetic cardiomyopathy through the modulation of autophagy, apoptosis, gut microbiota, and metabolites
por: Yang, Jinjin, et al.
Publicado: (2022)

Proteomic and metabolomic analyses reveal the novel targets of spermine for alleviating diabetic cardiomyopathy in type II diabetic mice
por: Sun, Jian, et al.
Publicado: (2022)

FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model
por: Wang, Lexun, et al.
Publicado: (2021)

Spermidine Affects Cardiac Function in Heart Failure Mice by Influencing the Gut Microbiota and Cardiac Galectin-3
por: Chen, Yufeng, et al.
Publicado: (2021)

Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice
por: Pappritz, Kathleen, et al.
Publicado: (2021)

Galectin functions in cancer-associated inflammation and thrombosis
por: Kruk, Linus, et al.
Publicado: (2023)

Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy
por: Kain, Vasundhara, et al.
Publicado: (2017)

Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy
por: Kaludercic, Nina, et al.
Publicado: (2020)

Molecular Mechanisms and Epigenetic Regulation in Diabetic Cardiomyopathy
por: Mittal, Anupam, et al.
Publicado: (2021)

Galectin-3 Mediates Thrombin-Induced Vascular Smooth Muscle Cell Migration
por: Tian, Lei, et al.
Publicado: (2021)

Potential diabetic cardiomyopathy therapies targeting pyroptosis: A mini review
por: Jia, Yu, et al.
Publicado: (2022)

Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological Strategies
por: Muñoz-Córdova, Felipe, et al.
Publicado: (2021)

Editorial: Understanding Molecular Mechanisms in Diabetic Cardiomyopathy (DCM)
por: Muthu, Sakthijothi, et al.
Publicado: (2022)

1-MNA Ameliorates High Fat Diet-Induced Heart Injury by Upregulating Nrf2 Expression and Inhibiting NF-κB in vivo and in vitro
por: Song, Ziguang, et al.
Publicado: (2021)

Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study
por: Liu, Mao, et al.
Publicado: (2021)

Exploring the Causal Effects of Circulating ST2 and Galectin-3 on Heart Failure Risk: A Mendelian Randomization Study
por: Wang, Xizhi, et al.
Publicado: (2022)

Programmed Exercise Attenuates Familial Hypertrophic Cardiomyopathy in Transgenic E22K Mice via Inhibition of PKC-α/NFAT Pathway
por: Wang, Haiying, et al.
Publicado: (2022)

Diagnostic Value of Serum Concentration of Galectin-3 in Patients With Heart Failure With Preserved Ejection Fraction
por: Jiang, Jing, et al.
Publicado: (2022)

Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy
por: He, Chao-Jie, et al.
Publicado: (2022)

Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
por: Mohan, Mohapradeep, et al.
Publicado: (2021)

Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy
por: Richter, Claudia, et al.
Publicado: (2021)

Skeletal Muscle Microvascular Dysfunction Manifests Early in Diabetic Cardiomyopathy
por: Loai, Sadi, et al.
Publicado: (2021)

Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure
por: Caravaca Perez, Pedro, et al.
Publicado: (2022)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Network Pharmacology-Based Analysis of the Pharmacological Mechanisms of Aloperine on Cardiovascular Disease
por: Huang, Bingwu, et al.
Publicado: (2020)

Association Between Serum Galectin-3 Levels and Coronary Stenosis Severity in Patients With Coronary Artery Disease
por: Li, Mingxing, et al.
Publicado: (2022)

Case Report: A Mysterious Giant Thrombus in the Right Atrium in a Patient With Dilated Cardiomyopathy
por: Lian, Ping-an, et al.
Publicado: (2022)

Cellular Protein Quality Control in Diabetic Cardiomyopathy: From Bench to Bedside
por: Kaur, Namrita, et al.
Publicado: (2020)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Clinical Approach to Assessment and Amelioration of Atherosclerotic Vascular Disease in Diabetes
por: Goldberg, Ronald B.
Publicado: (2020)

Biotin amelioration of nephrotoxicity in streptozotocin-induced diabetic mice
por: Aldahmash, Badr A., et al.
Publicado: (2015)

Abrogation of CC Chemokine Receptor 9 Ameliorates Ventricular Electrical Remodeling in Mice After Myocardial Infarction
por: Huang, Yan, et al.
Publicado: (2021)

Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase
por: Sharma, Arpeeta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0prmii6fv75oeet3l9g1847td8